Should dermatologists care about hepatic fibrosis and steatosis? Psoriasis first, hidradenitis suppurativa second [0.03%]
皮肤科医生应该关注肝纤维化和脂肪变性吗？银屑病第一，化脓性汗腺炎第二
Enzo Emanuele,Piercarlo Minoretti
Enzo Emanuele
Bioinformatic analysis of genetic changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3, and NPAS2 proteins in HCC patients [0.03%]
乙型肝炎相关性原发性肝癌患者CLOCK、BMAL1、CRY1、CRY2、PER1、PER2、PER3及NPAS2基因多态性生物信息学分析
Durmus Ayan,Ak Cagatay
Durmus Ayan
Background and aim: Genes related to the circadian rhythm control various biological processes. The aim of this study was to comprehensively investigate the mutational and mRNA profile of core circadian rhythm genes in he...
A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale [0.03%]
巴雷特量表：酒精性肝硬化患者肝移植术后预测饮酒复发的新方法
Veysel Umman,Tufan Gumus,Ebubekir Korucuk et al.
Veysel Umman et al.
Background and aim: Alcohol-induced liver disease has become one of the major causes of chronic liver disease worldwide with the increasing use of alcohol in society. The most important step in treatment is cessation of a...
Practice patterns and considerations in liver transplantation from living donors with high BMI: A review [0.03%]
肥胖供肝活体肝脏移植临床实践及考量：一篇综述
Carl Samaha,Hadi Chaaban,Cem Simsek et al.
Carl Samaha et al.
Living Donor Liver Transplantation (LDLT) is a valuable solution to the shortage of donor organs for patients with end-stage liver disease. However, the eligibility of obese donors for LDLT remains a subject of debate. This literature revie...
Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis? [0.03%]
肝移植患者的意外混合型肝细胞-胆管癌：预后更差吗？
Ender Anilir,Alihan Oral,Tolga Sahin et al.
Ender Anilir et al.
Background and aim: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being ra...
Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score's prediction factor for survival? [0.03%]
钇90放射栓塞治疗中晚期肝细胞癌的效果如何？白蛋白-胆红素评分对生存率的预测价值有多大？
Sami Evirgen,Bilger Cavus,Suut Gokturk et al.
Sami Evirgen et al.
Background and aim: Radioembolization (RE) is a one of the palliative treatments that have been used to down stage and/or increase the survival time in intermediate-advanced stages of HCC. We aimed to evaluate the clinica...
Recurrent early-onset severe obstetric cholestasis in a patient with two variants in the ABCB4 gene [0.03%]
ABCB4基因两种变异患者的复发性早期重度妊娠胆汁淤积症
Mohammad Fawad Khattak,Sam Thomson
Mohammad Fawad Khattak
A 36-year-old patient presented with severe early-onset obstetric cholestasis on a background of having pre-term induction of labor at 33 weeks during her only previous pregnancy. The patient had significantly abnormal liver biochemistry wi...
Does mtori base immunosuppression offer survival advantage after liver transplantation for hepatocellular carcinoma? Systematic review and meta-analysis of randomized controlled trials [0.03%]
基于mTOR的免疫抑制是否能为肝细胞癌受者的肝移植术后生存带来优势？随机对照试验系统评价和meta分析
Ali ALoun,Ez El Din Abu-Zeid,Ibrahim Umar Garzali
Ali ALoun
Recurrence is still a problem after liver transplant for hepatocellular carcinoma (HCC). We performed an updated systematic review and meta-analysis of randomized controlled trials comparing tumor recurrence of mammalian target of rapamycin...
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients [0.03%]
抗线粒体M2抗体阳性偶然受检者中原发性胆汁性胆管炎的发病风险
Ilkay Ergenc,Busra Gozaydinoglu,Caglayan Keklikkiran et al.
Ilkay Ergenc et al.
Background and aim: This study investigated the risk of the development of primary biliary cholangitis (PBC) in individuals who were incidentally identified as having positive antimitochondrial antibodies (AMA)-M2. ...
Fingolimod induced fulminant liver failure requiring liver transplantation: A case report [0.03%]
芬戈莫德致急性肝衰竭一例并肝脏移植治疗报告
Ali Riza Caliskan,Muhsin Murat Muhip Harputluoglu,Emine Samdanci et al.
Ali Riza Caliskan et al.
Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discon...
Case Reports
Hepatology forum. 2023 May 18;4(2):74-77. DOI:10.14744/hf.2022.2022.0033 2023